[1]
“HYDROXYUREA TREATMENT AND REDUCTION IN TRANSFUSION DEMAND IN Β-THALASSEMIA MAJOR: EVIDENCE FROM THE HOSPITAL-BASED STUDY IN KARACHI”, Biosci. Insights., vol. 3, no. 02, pp. 351–361, Aug. 2026, Accessed: Nov. 10, 2026. [Online]. Available: https://biosciinsights.com/index.php/BI/article/view/93